XML 43 R32.htm IDEA: XBRL DOCUMENT v3.8.0.1
STRATEGIC ARRANGEMENTS (Details) - USD ($)
3 Months Ended
Aug. 02, 2017
Dec. 01, 2007
Mar. 31, 2018
Mar. 31, 2017
Dec. 31, 2017
Research and Development Arrangement, Contract to Perform for Others [Line Items]          
Minimum annual royalty payment     $ 500,000    
CASE          
Research and Development Arrangement, Contract to Perform for Others [Line Items]          
Royalty expense     33,000 $ 38,000  
Royalty payable     $ 33,000   $ 37,000
Royalty Agreement Terms | CASE          
Research and Development Arrangement, Contract to Perform for Others [Line Items]          
Royalty agreement period 10 years 10 years      
Minimum annual royalty payment   $ 10,000      
Royalty agreement percentage   3.00%      
Milestone payments for FDA approval to sell our products within the United States   $ 5,000      
Milestone payment for general product launch   $ 10,000